EP Patent

EP2859911A1 — Vascular access port devices with incorporated sensors

Assigned to qSTAR Medical Sas · Expires 2015-04-15 · 11y expired

What this patent protects

Described herein is a vascular access port device (300) which provides both blood monitoring and providing access to a vascular element (200) implanted within a hemodialysis patient. The device (300) comprises a body (310) connectable to the vascular element (300) at one end ther…

USPTO Abstract

Described herein is a vascular access port device (300) which provides both blood monitoring and providing access to a vascular element (200) implanted within a hemodialysis patient. The device (300) comprises a body (310) connectable to the vascular element (300) at one end thereof, and a cartridge (330) mounted within the body (310). The cartridge (330) comprises an electrode set (375) arranged on a distal end (340a) of a septum (340) for sensing blood chemistry, associated electronics (360, 365, 370) for processing signals sensed by the electrode set (375), and inductive antenna arrangement (380, 400) for transmitting the processed signals to a remote location.

Drugs covered by this patent

Patent Metadata

Patent number
EP2859911A1
Jurisdiction
EP
Classification
Expires
2015-04-15
Drug substance claim
No
Drug product claim
No
Assignee
qSTAR Medical Sas
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.